Outcome after depot gonadotrophin-releasing hormone agonist treatment for central precocious puberty: Effects on body mass index and final height

European Journal of Endocrinology

Volumn 153, Issue 3, 2005, Pages 463-464

  Traggiai, C ^a   Perucchin, P Polo ^a   Zerbini, K ^a   Gastaldi, R ^a   De Biasio, P ^a   Lorini, Renata ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN AGONIST;

ABDOMINAL PAIN; ADOLESCENT; ARTHRALGIA; BODY HEIGHT; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEADACHE; HUMAN; INCREASED APPETITE; LETTER; MENSTRUAL CYCLE; OBESITY; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPOTTING; STUDENT T TEST; TREATMENT OUTCOME;

BODY HEIGHT; BODY MASS INDEX; CHILD; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; LONGITUDINAL STUDIES; OBESITY; PUBERTY, PRECOCIOUS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 26244445979     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.01975     Document Type: Letter

References (8)

1. Arrigo T, De Luca F, Antoniazzi F, Galluzzi F, Segni M, Rosano M, Messina MF & Lombardo F. Reduction of baseline body mass index under gonadotropin-suppressive therapy in girls with idiopathic precocious puberty. European Journal of Endocrinology 2004 150 533-537.
2. Greulich WW & Pyle SI. Radiographic Atlas of Skeletal Development of the Hand and Wrist, edn 2. Stanford, CA: Stanford University Press, 1959.
3. Rolland-Cachera MF, Cole TJ, Sempe M, Tichet J, Rossignol C & Charraud A. Body mass index variations: centiles from birth to 87 years. European Journal of Clinical Nutrition 1991 45 13-21.
4. Kanbur NO, Derman O & Kinik E. Prevalence of obesity in adolescents and the impact of sexual maturation stage on body mass index in obese adolescents. International Journal of Adolescent Medicine and Health 2002 14 61-65.
5. Chiumello G, Brambilla P, Guarneri MP, Russo G, Manzoni P & Sgaramella P. Precocious puberty and body composition: effects of GnRH analog treatment. Journal of Pediatric Endocrinology and Metabolism. 2000 13 (Suppl 1) 791-794.
6. Palmert MR, Mansfield MJ, Crowley WF Jr, Crigler JF Jr, Crawford JD & Boepple PA. Is obesity an outcome of gonadotropin-releasing hormone agonist administration? Analysis of growth and body composition in 110 patients with central precocious puberty. Journal of Clinical Endocrinology and Metabolism 1999 84 4480-4488.
7. Heger S, Partsch CJ & Sippell WG. Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function. Journal of Clinical Endocrinology and Metabolism 1999 84 4583-4590.
8. Feuillan PP, Jones JV, Barnes K, Klein KO & Cutler GB Jr. Follow-up of children and young adults after GnRH-agonist therapy for central precocious puberty. Journal of Endocrinological Investigation 2001 24 734-736.